Stay updated on Clinical Trial: TTF+IO±CTLA-4 for Recurrent Glioblastoma
Sign up to get notified when there's something new on the Clinical Trial: TTF+IO±CTLA-4 for Recurrent Glioblastoma page.

Latest updates to the Clinical Trial: TTF+IO±CTLA-4 for Recurrent Glioblastoma page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page revision was updated from v3.6.2 to v3.6.3, signaling a newer page version. This appears to be a small maintenance update rather than a substantive change to study details.SummaryDifference0.1%

- Check21 days agoChange DetectedRevision label on the page updated from v3.6.0 to v3.6.2. This indicates a backend/template update, not new study data or visible content changes.SummaryDifference0.1%

- Check35 days agoChange DetectedRecruitment status is updated to indicate enrollment has ended. The page also shows a formatting change to the Intervention/Treatment label and adds a v3.6.0 revision note.SummaryDifference0.5%

- Check42 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, indicating a new revision of the page. This update is a maintenance/version control change and does not alter the study details.SummaryDifference0.1%

- Check64 days agoChange DetectedA new revision entry, Revision: v3.5.4, was added to the page's revision history, indicating an update to the content. The previous Revision: v3.5.3 entry is superseded.SummaryDifference0.1%

- Check86 days agoChange DetectedThe page’s displayed ClinicalTrials.gov revision/version was updated from **v3.5.2** to **v3.5.3**.SummaryDifference0.1%

Stay in the know with updates to Clinical Trial: TTF+IO±CTLA-4 for Recurrent Glioblastoma
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: TTF+IO±CTLA-4 for Recurrent Glioblastoma page.